In a single stock transaction between private parties, the majority ownership of BSD Medical Corp., 2188 W. 2200 South, was transferred from R. Carter Pate to an investor group comprised of company employees and Dr. Gerhard Senne-wald, president and chief executive officer of Medizin Technik.
The sale involved 68 percent of the company and included all securities formerly held by the Nelson Bunker Hunt Liquidating Trust, Dallas, and all preferred securities formerly held by Alan Himber, the previous chairman, president and chief executive officer. Pate is trustee of the trust.Steve Carwell, president and chief executive officer, said, "We are very pleased to see majority ownership of BSD in the hands of our employees and view this transaction as an important step in positioning the company for sig-nif-icant future growth."
BSD develops and produces advanced hyperthermia systems for cancer therapy and has entered the international market place with technology for the non-surgical treatment of various benign diseases of the prostate.